This phenomenon of anti-IFN autoantibodies has also been observed in SLE patients, with the presence of de novo or induced anti-IFNα autoantibodies that normalized the type I IFN signature [19,57]. This evidence concerns the gene IFNA17 and systemic lupus erythematosus.